Mitesh

Update 17/06/2025 – Correction to PIP codes in the table below. Pharmacy teams should be aware that Pfizer Limited has recently ceased supplying a number of its well-established brands and released generic equivalent versions instead. The table below includes the Pfizer products that have recently transitioned from brand to generic along with information on ordering [...]

The post Update – Pfizer brands now available as generics appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets, Opella Healthcare Drug alert number: EL(25)A/26 Date issued: 10 June 2025 Opella Healthcare UK LTD has informed the MHRA that there is an error on the artwork for the outer carton of Dulcolax® Adult 5mg GR Tablets (packsize 20 count). The dose instruction incorrectly states [...]

The post MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets (Opella Healthcare) appeared first on Community Pharmacy England.

In light of surveillance data indicating that circulation of influenza in the community has returned to baseline levels, the Department of Health and Social Care has published an alert to inform prescribers working in primary care and pharmacy teams that antiviral medicines should no longer be prescribed.  Community pharmacists should no longer supply antiviral medicines [...]

The post End of antiviral medicine prescribing for 2024/25 influenza season appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Various Chemidex Pharma Ltd Products Drug alert number: EL(25)A/21 Date issued: 13 May 2025 Chemidex Pharma Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in their topical steroid products does not contain all the required safety information. Cartons for the products/batches listed are missing side effect information [...]

The post MHRA Class 4 Medicines Defect Notification: Various Chemidex Pharma Ltd Products appeared first on Community Pharmacy England.

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 2 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 May 2025. This takes the total [...]

The post Ivermectin 3mg tablets and Paxlovid 150mg/100mg tablets added to the Discount Not Deducted (DND) list from May 2025 appeared first on Community Pharmacy England.